Traws Pharma, Inc.

Q4 2024 13F Holders

Symbol
TRAW
CUSIP
68232V884
Type
Equity
Class
COM NEW
Num filings
19
Total reported value, excl. options
$10.2 M
Manager Report Date Value ($000) Shares Option Type